Discussion of the Feasible Prevalence of Providing the Routine Human Immunodeficiency Virus Screening in Pregnant Women

doi:10.3877/cma.j.issn.1673-5250.2011.06.003

Objective

To discuss the feasible prevalence of providing the routine human immunodeficiency virus(HIV) screening in pregnant women by evaluating the cost-benefits of integrated prevention of mother-to-child transmission(PMTCT) of HIV in four high-incidence counties.

Methods

Data of local resource investment and total cost for PMTCT in 4 counties in China from 2003-2006 were collected. Cost analysis and cost-benefits analysis were conduct. The feasible prevalence was obtained when the economic save and the cost of the programme was equal.

Results

The feasible HIV prevalence for HIV screening in pregnant women was 0.0596% and 0.036% depending on local and national GDP, respectively, base on total cost perspective.

Conclusion

It is time for China to scale up the HIV screening service in pregnant women.

Key words: Acquired immunodeficiency syndrome, disease vertical transmission, infection control, cost-benefit analysis

	1　Gui XE, Luo JL，Zhuang K. The survey of HIV transmutation among the family [J]. Chin J Epidemiol，2003，24：396.[桂希恩，骆嘉拉，庄柯．艾滋病病毒家庭内传播的调查[J]．中华流行病学杂志，2003，24：396.]
	2　Wunder D, Evison JM. Antiretroviral therapy and pregnancy[J]. Ther Umsch, 2005，62(1)：37－42.
	3　Guo Jm, Wang YM, Wang ZY，et al. Analysis on AIDS－associated social economic burden in countryside with high－incidence of AIDS[J]．Chin J public Health，2006，22：998－1000.[郭金玲，王宇明，王仲阳，等．农村艾滋病高发地区社会疾病经济负担分析[J]．中国公共卫生，2006，22：998－1000.]
	4　Murray DJ, Lopez AD. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020[M]. Boston: Harvard University Press，1996，10－15.
	5　Marseille E．，J. G. Kahn, R. Mmiro, et al. Cost－effectiveness of single－dose nevirapine regimen for mothers and babies to decrease vertical HIV－1 transmission in Sub－Saharan Africa [J]. Lancet, 1999，354(9181)：803－809.
	6　Dai ZC. Global and China HIV/AIDS epidemic and prevention and control strategy[J]. Chin J School Health，2005，26(1)：84－88.[戴志澄．全球/中国HIV/AIDS流行状况及预防与控制策略[J]．中国学校卫生，2005，26(1)：84－88.]
	7　Postma MJ, Beck EJ, Mandalia S, et al. Universal HIV screening of pregnant women in England: Cost effectiveness analysis [J]. Br Med J, 1999，318：1656－1660.
	8　Immergluch LC, Cull WL, Schwartz A, et al. Cost－effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago [J]. Pediatrics, 2000, 105：E54.
	9　Bramley D, Graves N, Walker D. The cost effectiveness of universal antenatal screening for HIV in New Zealand [J]. AIDS, 2003, 17：741－748.
	10　Graves N, Walker DG, McDonald AM, et al. Would universal antenatal screening for HIV infection be cost－effective in a setting of very low prevalence? Modelling the data for Australia [J]. J Infect Dis 2004, 190：166－174.

[1]	Lei Yang, Dongqiong Xiao, Yisi Zhong. Current research status between oral microbiome and common non-oral diseases in children[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2021, 17(05): 510-515.
[2]	Zihao Cui, Yue Yang, Jingfeng Zhao, Guang Feng, Xiaoye Tuo. Clinical analysis of Fournier gangrene wound infection control strategy and wound repair[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2024, 19(04): 319-323.
[3]	Duyin Jiang, Shanshan Jia, Xinglei Wang. Burn treatment and wound repair[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2021, 16(04): 283-288.
[4]	Lingjie Wu, Ruilie Chen, Xiangming Xiao, Genglong Guo, Zhongbin Lin, Haisheng Zhang, Min Zhou, Miaohua Chen. Epidemiological characteristics and survival analysis of patients with human immunodeficiency virus infection and acquired immune deficiency syndrome after highly active antiretroviral therapy in a general hospital in Shantou, Guangdong Province from 2005 to 2021[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2024, 18(04): 207-214.
[5]	Lingjie Wu, Ruilie Chen, Guijia Chen, Xiangming Xiao, Zhongbin Lin. Antiviral treatment of two cases with human immunodeficiency virus complicated with severe acute respiratory syndrome coronavirus 2 co-infection and literatures review[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(04): 282-286.
[6]	Rui Yuan, Wenjia Hu, Xien Gui, Yajun Yan, Ling Feng, Hengning Ke, Yong Xiong, Rongrong Yang. Application of refined lymphocyte subsets detection on patients with human immunodeficiency virus infection/acquired immunodeficiency syndrome[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(02): 84-91.
[7]	Tongtong Wang, Chunyu Zhu, Yingchu Liu, Guiju Gao. Current situation and mechanism of liver function injury in patients with acquired immunodeficiency syndrome combined with pneumocystis pneumonia treated by Trimethoprim sulfamethoxazole[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(02): 79-83.
[8]	Yanxue Wang, Hongying Hu, Xingang Li, Xingmeng Lu. Five cases with acquired immunodeficiency syndrome and Graves’ disease associated with immune reconstitution inflammatory syndrome and literature review[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(01): 65-70.
[9]	Fei Tian, Song Gao, Zheng Li, Yinghui Wang, Yuanyuan Wang. Survival period and influencing factors of 1 076 patients with human immunodeficiency virus infection/acquired immunodeficiency syndrome in Dongcheng District, Beijing from 1989 to 2020[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2022, 16(02): 100-107.
[10]	Yaqin Qin, Yingmei Qin. Clinical analysis of 8 369 patients with human immunodeficiency virus infection/acquired immunodeficiency syndrome complicated with hepatitis B virus and/or hepatitis C virus infection[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2021, 15(05): 295-302.
[11]	Cailing Chen, Jinfeng Ji, Yuhong Wang, Jing Xu, Xiangan Zhu, Wei Li, Xiyan Hao, Aiqin Li. Integrated treatment management and countermeasures of emergency abdominal multiple injuries during COVID-19 epidemic prevention and control[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2022, 16(05): 560-563.
[12]	Enzhu Zhou, min Liu, Qiu Wan, Jingwen Liu, Lixin Tang. Clinical characteristics of acquired immunodeficiency syndrome complicated with chronic obstructive pulmonary disease[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(01): 78-82.
[13]	Jiamin Lin, Haiqi Ding, Changyu Huang, Yang Chen, Ying Huang, Wenming Zhang, Xinyu Fang. Survival with spacer can be used as an alternative for patients with chronic PJI who cannot tolerate two-stage revision---- A single center cohort study[J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2024, 10(02): 88-95.
[14]	Pei Xu, Meilian Deng, Wen Sun, Xingfei Pan, Dunjin Chen, Mingxing Liu. "Three-line prevention and control" management model of obstetrics and gynecology outpatient patients during the epidemic of COVID-19[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2022, 11(01): 27-32.
[15]	Lanlan Li, Yihua Gong, Yongxin Chen, Chuncui Zheng, Shijian Yi. Effect of failure mode and effects analysis on enhancing compliance with standard precautions among hospital cleaning personnel[J]. Chinese Journal of Hygiene Rescue(Electronic Edition), 2024, 10(05): 277-280.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export